APA (7th ed.) Citation

Mirioglu, S., Hocaoglu, R. H., Velioglu, A., Ozluk, Y., Dirim, A. B., Oruc, A., . . . Caliskan, Y. (2024). Prognosis is still poor in patients with posttransplant C3 glomerulopathy despite eculizumab use. Clinical Kidney Journal, 17(7), 1. https://doi.org/10.1093/ckj/sfae190

Chicago Style (17th ed.) Citation

Mirioglu, Safak, Rabia Hacer Hocaoglu, Arzu Velioglu, Yasemin Ozluk, Ahmet Burak Dirim, Aysegul Oruc, Ozgur Akin Oto, Halil Yazici, and Yasar Caliskan. "Prognosis Is Still Poor in Patients with Posttransplant C3 Glomerulopathy Despite Eculizumab Use." Clinical Kidney Journal 17, no. 7 (2024): 1. https://doi.org/10.1093/ckj/sfae190.

MLA (9th ed.) Citation

Mirioglu, Safak, et al. "Prognosis Is Still Poor in Patients with Posttransplant C3 Glomerulopathy Despite Eculizumab Use." Clinical Kidney Journal, vol. 17, no. 7, 2024, p. 1, https://doi.org/10.1093/ckj/sfae190.